<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<GBSeq>

    <GBSeq_locus>LZ176619</GBSeq_locus>
    <GBSeq_length>568</GBSeq_length>
    <GBSeq_strandedness>double</GBSeq_strandedness>
    <GBSeq_moltype>DNA</GBSeq_moltype>
    <GBSeq_topology>linear</GBSeq_topology>
    <GBSeq_division>PAT</GBSeq_division>
    <GBSeq_update-date>28-OCT-2017</GBSeq_update-date>
    <GBSeq_create-date>28-OCT-2017</GBSeq_create-date>
    <GBSeq_definition>JP 2017515508-A/7: Virus like vesicles (VLVs) based vaccines to prevent or treat chronic hepatitis B virus (HBV) infection</GBSeq_definition>
    <GBSeq_primary-accession>LZ176619</GBSeq_primary-accession>
    <GBSeq_accession-version>LZ176619.1</GBSeq_accession-version>
    <GBSeq_other-seqids>
      <GBSeqid>dbj|LZ176619.1|</GBSeqid>
      <GBSeqid>pat|JP|2017515508|7</GBSeqid>
      <GBSeqid>gi|1271871768</GBSeqid>
    </GBSeq_other-seqids>
    <GBSeq_keywords>
      <GBKeyword>JP 2017515508-A/7</GBKeyword>
    </GBSeq_keywords>
    <GBSeq_source>Hepatitis B virus</GBSeq_source>
    <GBSeq_organism>Hepatitis B virus</GBSeq_organism>
    <GBSeq_taxonomy>Viruses; Retro-transcribing viruses; Hepadnaviridae; Orthohepadnavirus</GBSeq_taxonomy>
    <GBSeq_references>
      <GBReference>
        <GBReference_reference>1</GBReference_reference>
        <GBReference_position>1..568</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Rose,J.</GBAuthor>
          <GBAuthor>Reynolds,T.</GBAuthor>
          <GBAuthor>Robek,M.</GBAuthor>
        </GBReference_authors>
        <GBReference_title>Virus like vesicles (VLVs) based vaccines to prevent or treat chronic hepatitis B virus (HBV) infection</GBReference_title>
        <GBReference_journal>JP2017515508-A 7 15-JUN-2017 Yale University</GBReference_journal>
      </GBReference>
    </GBSeq_references>
    <GBSeq_comment>OS Hepatitis B virus~PN JP 2017515508-A/7~PD 15-JUN-2017~PF 11-MAY-2015 JP 2017512646~PR 16-MAY-2014 US 61/994166~PA Yale University~PI john rose,tracy reynolds,michael robek~PT 'Virus like vesicles (VLVs) based vaccines to prevent or treat~PT chronic~PT hepatitis B virus (HBV) infection'~PS N7~CC~FH Key Location/Qualifiers.</GBSeq_comment>
    <GBSeq_feature-table>
      <GBFeature>
        <GBFeature_key>source</GBFeature_key>
        <GBFeature_location>1..568</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>1</GBInterval_from>
            <GBInterval_to>568</GBInterval_to>
            <GBInterval_accession>LZ176619.1</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>organism</GBQualifier_name>
            <GBQualifier_value>Hepatitis B virus</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>mol_type</GBQualifier_name>
            <GBQualifier_value>unassigned DNA</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>db_xref</GBQualifier_name>
            <GBQualifier_value>taxon:10407</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
    </GBSeq_feature-table>
    <GBSeq_sequence>ttaattaaaatggacatcgacccttataaagaatttggagctactgtggagttactctcgtttttgccttctgacttctttccttcagtacgagatcttctagataccgcctcagctctgtatcgggaagccttagagtctcctgagcattgttcacctcaccatactgcactcaggcaagcaattctttgctggggggaactaatgactctagctacctgggtgggtgttaatttggaagatccagcgtctagagacctagtagtcagttatgtcaacactaatatgggcctaaagttcaggcaactcttgtggtttcacatttcttgtctcacttttggaagagaaacagttatagagtatttggtgtctttcggagtgtggattcgcactcctccagcttatagaccaccaaatgcccctatcctatcaacacttccggagactactgttgttagacgacgaggcaggtcccctagaagaagaactccctcgcctcgcagacgaaggtctcaatcgccgcgtcgcagaagatctcaatctcgggaatctcaatgtcctgcaggag</GBSeq_sequence>
  </GBSeq>
